Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial.
19 Apr, 2022 | 02:25h | UTCOmicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial – Reuters
Commentary on Twitter
In China, #Omicron-specific vaccines are slated for clinical trials. The vaccine candidates were developed by a Sinopharm subsidiary and Sinovac Biotech. The vaccines are headed to clinical trials in Hong Kong https://t.co/6Y9LsGCKbn
— delthia ricks ? (@DelthiaRicks) April 17, 2022